Objective: To explore the long-term drug treatment willingness and influencing factors of endometriosis. Method: The information was collected from 200 endometriosis patients who were admitted to the gynecology clinic and ward of Shaanxi Provincial People’s Hospital from June 2019 to December 2020. Data was analyzed by univariate and multivariate logistic regression analysis. The influence of age, education level, diagnosis method, pre-treatment pain score, cyst diameter, EMs disease cognition and monthly treatment cost, pain relief satisfaction after treatment, drug toxicity tolerance and drug use method on the willingness and duration of long-term drug treatment was investigated. Results: The results of multivariate logistic regression analysis showed that diagnostic methods (OR = 0.304, 95% CI 0.127 - 0.728), pre-treatment pain score (OR = 1.415, 95% CI 1.237 - 1.620) and EMs disease cognition (OR = 1.058, 95% CI 1.030 - 1.087) were the main factors affecting the treatment willingness of EMs patients, and the drug use method was a key factor affecting the treatment duration (P<0.05). Conclusion: In the future, the adequate health education should be given to the EMs patients to promote their cognitive level of disease and recognition of diagnostic methods. At the same time, patients’ preferences for treatment measures should be combined to improve their long-term drug treatment willingness.

Jialan Chen, Xin Shen, Qinfeng Liu, Fan Wang. Willingness and Influencing Factors of Long-Term Drug Treatment in Endometriosis Patients. International Journal of Frontiers in Medicine (2022), Vol. 4, Issue 9: 1-5. https://doi.org/10.25236/IJFM.2022.040901.

[1] Adamson G D, Kennedy S, Hummelshoj L. Creating Solutions in Endometriosis: Global Collaboration through the World Endometriosis Research Foundation [J]. Journal of Endometriosis, 2010, 2(1): 3-6.

[2] Soliman A M, Surrey E, Bonafede M et al. Real-World Evaluation of Direct and Indirect Economic Burden Among Endometriosis Patients in the United States [J]. Advances in Therapy, 2018, 35(3): 408-423.

[3] Shafrir A L, Farland L V, Shah D K et al. Risk for and consequences of endometriosis: A critical epidemiologic review [J]. Best practice & research:Clinical obstetrics & gynaecology, 2018, 51: 1-15.

[4] Sampson J A. Endometrial carcinoma of the ovary, arising in endometrial tissue in that organ [J]. Archives of surgery, 1925, 10(1): 1-72.

[5] Frcog R G M. Endometriosis: an invasive disease [J]. Gynaecological Endoscopy, 2001, 10(2): 79-82.

[6] Vercellini P, Vigano P, Somigliana E et al. Endometriosis: pathogenesis and treatment [J]. Nat Rev Endocrinol, 2014, 10(5): 261-275.

[7] Chen L C, Hsu J W, Huang K L et al. Risk of developing major depression and anxiety disorders among women with endometriosis: A longitudinal follow-up study [J]. J Affect Disord, 2016, 190: 282-285.

[8] Pluchino N, Wenger J M, Petignat P, et al. Sexual function in endometriosis patients and their partners: effect of the disease and consequences of treatment [J]. Hum Reprod Update, 2016, 22(6): 762-774.

[9] Zhou Y F. Patients with endometriosis need long term management [J]. Chinese Journal of Obstetrics and Gynecology, 2017, 52(03): 145-146.

[10] Endometriosis Committee, Chinese Obstetricians and Gynecologists Association; Cooperative Group of Endometriosis, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association. Chinese consensus on the long term management of endometriosis [J]. Chinese Journal of Obstetrics and Gynecology, 2018, 53(12): 836-841.

[11] Cooperative Group of Endometriosis, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association. Guideline for the diagnosis and treatment of endometriosis [J]. Chinese Journal of Obstetrics and Gynecology, 2015, 50(03): 161-169.

[12] Peng C, Zhou Y F. Application and selection of medical treatment in the long-term management of endometriosis [J]. Chinese Journal of Practical Gynecology and Obstetrics, 2021, 37(03): 303-308.